Literature DB >> 31721176

Adenoviral strategies to overcome innate cellular responses to infection.

Sook-Young Sohn1, Patrick Hearing1.   

Abstract

Viruses alter host cell processes to optimize their replication cycle. Human adenoviruses (Ad) encode proteins that promote viral macromolecular synthesis and counteract innate and adaptive responses to infection. The focus of this review is on how Ad evades innate cellular responses to infection, including an interferon (IFN) response and a DNA damage response (DDR). Ad blocks the IFN response by inhibiting cytoplasmic signaling pathways and the activation of IFN-stimulated genes (ISGs), as well as the functions of ISG products, such as PML. Ad also inhibits DDR sensors, for instance, the Mre11-Rad50-Nbs1 complex, and DDR effectors like DNA ligase IV. These innate cellular responses impact many different viruses, and studies on Ad have provided broad insight into these areas.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  DNA damage response; E1A; E1B; E4; PML; SUMO; adenovirus; innate cellular responses; interferon

Mesh:

Substances:

Year:  2019        PMID: 31721176      PMCID: PMC6928427          DOI: 10.1002/1873-3468.13680

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  82 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation.

Authors:  Andrew N Blackford; Roger J A Grand
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

3.  The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components.

Authors:  K N Leppard; R D Everett
Journal:  J Gen Virol       Date:  1999-04       Impact factor: 3.891

4.  Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification.

Authors:  G J Fonseca; G Thillainadesan; A F Yousef; J N Ablack; K L Mossman; J Torchia; J S Mymryk
Journal:  Cell Host Microbe       Date:  2012-06-14       Impact factor: 21.023

5.  Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation.

Authors:  Sook-Young Sohn; Patrick Hearing
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 6.  The transcriptional corepressor CtBP: a foe of multiple tumor suppressors.

Authors:  G Chinnadurai
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

7.  Comparison of protein expression during wild-type, and E1B-55k-deletion, adenovirus infection using quantitative time-course proteomics.

Authors:  Yen Rong Fu; Andrew S Turnell; Simon Davis; Kate J Heesom; Vanessa C Evans; David A Matthews
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

8.  Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.

Authors:  T Carvalho; J S Seeler; K Ohman; P Jordan; U Pettersson; G Akusjärvi; M Carmo-Fonseca; A Dejean
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

9.  Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA.

Authors:  A Gupta; S Jha; D A Engel; D A Ornelles; A Dutta
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

10.  SPOC1-mediated antiviral host cell response is antagonized early in human adenovirus type 5 infection.

Authors:  Sabrina Schreiner; Sarah Kinkley; Carolin Bürck; Andreas Mund; Peter Wimmer; Tobias Schubert; Peter Groitl; Hans Will; Thomas Dobner
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

View more
  6 in total

1.  Rb-E2F-HDAC Repressor Complexes Control Interferon-Induced Repression of Adenovirus To Promote Persistent Infection.

Authors:  Sydney Snaider; Yueting Zheng; Patrick Hearing
Journal:  J Virol       Date:  2022-05-12       Impact factor: 6.549

Review 2.  En Guard! The Interactions between Adenoviruses and the DNA Damage Response.

Authors:  Tamar Kleinberger
Journal:  Viruses       Date:  2020-09-07       Impact factor: 5.048

3.  The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus.

Authors:  Fanny Georgi; Vardan Andriasyan; Robert Witte; Luca Murer; Silvio Hemmi; Lisa Yu; Melanie Grove; Nicole Meili; Fabien Kuttler; Artur Yakimovich; Gerardo Turcatti; Urs F Greber
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures.

Authors:  Aleksei A Stepanenko; Anastasiia O Sosnovtseva; Marat P Valikhov; Anastasia A Chernysheva; Sergey A Cherepanov; Gaukhar M Yusubalieva; Zsolt Ruzsics; Anastasiia V Lipatova; Vladimir P Chekhonin
Journal:  Mol Ther Oncolytics       Date:  2021-12-21       Impact factor: 7.200

Review 5.  Genetic Modifications That Expand Oncolytic Virus Potency.

Authors:  Francisca Cristi; Tomás Gutiérrez; Mary M Hitt; Maya Shmulevitz
Journal:  Front Mol Biosci       Date:  2022-01-26

6.  A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus.

Authors:  Enkhjin Saruuldalai; Jiyoung Park; Dongmin Kang; Seung-Phil Shin; Wonkyun Ronny Im; Hwi-Ho Lee; Jiyoung Joan Jang; Jong-Lyul Park; Seon-Young Kim; Jung-Ah Hwang; Young-Dong Kim; Jung-Hoon Lee; Eun Jung Park; Yeon-Su Lee; In-Hoo Kim; Sang-Jin Lee; Yong Sun Lee
Journal:  Mol Ther Oncolytics       Date:  2022-02-20       Impact factor: 7.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.